CLINICAL_TRIALS
trial_result
· 2025-11-26
Clinical Trial Update: Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) [Phase 3]
Summary
Clinical trial update indicating that Fasedienol nasal spray is being studied for acute treatment of social anxiety disorder in a Phase 3 PALISADE-3 trial and i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VistaGen Therapeutics, Inc. | Conditions: Social Anxiety Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING